Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: Preliminary results in a canine model

Academic Radiology

Volumn 22, Issue 5, 2015, Pages 646-652

  Turkbey, Baris ^a   Hoyt, Robert F ^b,c   Agarwal, Harsh K ^a,d   Bernardo, Marcelino ^a,c   Sankineni, Sandeep ^a   Johnson, Linda ^a   Grant, Kinzya B ^a   Rais Bahrami, Soroush ^a   Kobayashi, Hisataka ^a   Wood, Bradford J ^a   Pinto, Peter A ^a   Griffiths, Gary L ^c   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

Gadofosveset trisodium; Human serum albumin; Lymph node; MRI

Indexed keywords

GADOFOSVESET; HUMAN SERUM ALBUMIN; CONTRAST MEDIUM; GADOLINIUM; ORGANOMETALLIC COMPOUND; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANINE MODEL; CONTRAST MEDIUM EXTRAVASATION; DOG; DRUG DOSE REDUCTION; INTRAPROSTATIC DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; SENTINEL LYMPH NODE; ANIMAL; DISEASE MODEL; HUMAN; IMAGE PROCESSING; LYMPH NODE METASTASIS; PATHOLOGY; PROCEDURES;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DOGS; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; PROSTATE; SERUM ALBUMIN;

EID: 84926975512     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2014.12.021     Document Type: Article

References (24)

1. Tiguert R., Gheiler E.L., Tefilli M.V., et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 1999, 53:367-371.
2. Oyen R.H., Van Poppel H.P., Ameye F.E., et al. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994, 190:315-322.
3. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
4. Bader P., Burkhard F.C., Markwalder R., et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 2002, 168:514-518.
5. Briganti A., Blute M.L., Eastham J.H., et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009, 55:1251-1265.
6. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003, 169:145-147. discussion 147-148.
7. Hövels A., Heesakkers R., Adang E., et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 2008, 63:387-395.
8. Thoeny H.C., Froehlich J.M., Triantafyllou M., et al. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 2014, 273:125-135.
9. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003, 348:2491-2499.
10. Schöder H., Herrmann K., Gönen M., et al. 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy. Clin Cancer Res 2005, 11:4761-4769.
11. Jeschke S., Beri A., Grüll M., et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 2008, 53:126-132.
12. Beri A., Janetschek G. Technology insight: radioguided sentinel lymph node dissection in the staging of prostate cancer. Nat Clin Pract Urol 2006, 3:602-610.
13. Ganswindt U., Schilling D., Müller A.C., et al. Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys 2011, 79:1364-1372.
14. Jeschke S., Nambirajan T., Leeb K., et al. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005, 173:1943-1946.
15. Lauffer R.B., Parmelee D.J., Ouellet H.S., et al. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996, 3(Suppl 2):S356-S358.
16. Nakajima T., Turkbey B., Sano K., et al. MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates. J Magn Reson Imaging 2014, 40(3):691-697.
17. Turkbey B., Kobayashi H., Hoyt R.F., et al. Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model. Lymphat Res Biol 2014, 12:32-36.
18. Hambrock T., Fütterer J.J., Huisman H.J., et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 2008, 43:686-694.
19. Kiselev M.A., Gryzunov Iu.A., Dobretsov G.E., et al. Size of a human serum albumin molecule in solution. Biofizika 2001, 46:423-427.
20. Ikomi F., Hanna G.K., Schmid-Schönbein G.W. Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology 1995, 196:107-113.
21. Lu Q., Bui D., Liu N.F., et al. Magnetic resonance lymphography at 3T: a promising noninvasive approach to characterise inguinal lymphatic vessel leakage. Eur J Vasc Endovasc Surg 2012, 43:106-111.
22. Holl G., Dorn R., Wengenmair H., et al. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009, 36:1377-1382.
23. Rousseau C., Rousseau T., Bridji B., et al. Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma. Eur J Nucl Med Mol Imaging 2012, 39:291-299.
24. van der Poel H.G., Buckle T., Brouwer O.R., et al. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 2011, 60:826-833.